Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
about
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyContemporary murine models in preclinical astrocytoma drug developmentComparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targetsThe Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma.Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoUse of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVGene therapy for malignant glioma.Immunosuppressive mechanisms in glioblastoma.Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaThe role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide.Strategies in gene therapy for glioblastoma.NCoR controls glioblastoma tumor cell characteristics.Molecular prognostic factors in glioblastoma: state of the art and future challenges.Radiation treatment and cancer stem cells.Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures.A paired comparison between glioblastoma "stem cells" and differentiated cells.Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma.BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected].High Jagged1 expression is associated with poor outcome in primary glioblastoma.Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells.Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
P2860
Q26998111-71A6FE7C-187B-42CC-A907-057F4E51DBCAQ27026937-C29AFDC2-4E7B-48BE-B9FF-D6F66C9F0D62Q28541360-BA9EF167-4C49-4DAD-AD49-593F0ACB75E5Q33652886-B12EFE05-CE51-47BD-A577-4706413BB1A9Q33720256-FFE344A0-87F0-4AA1-B386-122F3A8E8D23Q35591421-ADDD83C5-A30D-413B-82DF-381D83FB7E42Q35673628-EB17A28F-C050-4F67-A04F-1A5D48700BA5Q36224048-1A4FFC6D-6C8C-4369-B406-AE0DE3347CBDQ36531871-FBF5DFDA-9E58-476D-99B8-B132D7C0FAF6Q36575238-4A7ED2BD-47BF-463C-8085-5EB280BEA785Q36795940-FAE19548-FEC8-4117-8FCF-0699368F69B1Q37148255-5FFCFEE0-1ABD-4ABA-A8E4-4D26884E100CQ37420576-8CEDBC1D-C62B-4A3C-83F4-A47A2345BF69Q37492181-CE15B6BF-E31F-4DF5-926A-F9D57F968595Q38233134-0213F282-C589-408A-ADE3-1CB9595344CFQ38331970-5E74CBBF-462E-423D-B37A-8271169CB7FDQ38883388-51156BEE-2545-4A66-81EF-D462C6C0BAF7Q38959442-1BE4830F-B194-4D7B-957A-8EEF8700329EQ39007042-22EF89EA-2F15-46C9-BE6A-4603DD0C9E20Q39036566-838F8F2C-3BED-45A9-9A2B-41053F10CCFAQ39116798-0159AE06-3D9B-4734-966A-0A5BC768249CQ40373080-375D27FC-A1A3-4CB5-BDFE-29EEF5CED805Q41017478-8EEA1673-87DD-486F-9C10-AF14BCF2474BQ41516352-E9A78359-6EE6-4197-92CA-3FD94787314EQ41871901-F74C47D5-CBB9-476D-BCDA-CACB88406B03Q44737792-D9126204-3E5E-4731-9CDD-FF7D94937353Q44886553-CAA87B80-8C85-47E8-B324-54841A65D015Q52956451-4E77F5D8-0622-4048-B03C-796FBB5F5EBBQ58799521-FFF0D11B-A2EC-4708-AF77-59691972A22A
P2860
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@ast
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@en
type
label
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@ast
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@en
prefLabel
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@ast
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@en
P2860
P1433
P1476
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
@en
P2093
Costas George Hadjipanayis
Edjah Kweku-Ebura Nduom
P2860
P304
P356
10.1097/PPO.0B013E3182452E0D
P577
2012-01-01T00:00:00Z